LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
MCF7	CP466722	0.04	uM	LJP5	2	I12	72	hr	1235	4694	4356	1.0775	1.0838
MCF7	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	1235	1183	4070	0.2906	-0.0249
MCF7	Sorafenib	0.04	uM	LJP6	1	B12	72	hr	1235	4045	3974	1.0178	1.0211
MCF7	CP466722	0.04	uM	LJP5	1	I12	72	hr	1235	4735	4119	1.1495	1.1670
MCF7	CP724714	0.04	uM	LJP5	2	A12	72	hr	1235	3088	4356	0.7089	0.6552
MCF7	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	1235	1106	3974	0.2783	-0.0635
MCF7	AZD7762	0.04	uM	LJP6	3	L06	72	hr	1235	1833	4126	0.4442	0.2546
MCF7	AZD8055	0.04	uM	LJP6	2	A12	72	hr	1235	1464	4070	0.3597	0.1037
MCF7	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1235	4760	4119	1.1556	1.1736
MCF7	Sorafenib	0.04	uM	LJP6	3	B12	72	hr	1235	3858	4126	0.9350	0.9242
MCF7	CP466722	0.04	uM	LJP5	3	I12	72	hr	1235	5124	4326	1.1843	1.1962
MCF7	CP724714	0.04	uM	LJP5	1	A12	72	hr	1235	3347	4119	0.8125	0.7748
MCF7	AZD8055	0.04	uM	LJP6	3	A12	72	hr	1235	1129	4126	0.2736	-0.0504
MCF7	CP724714	0.04	uM	LJP5	3	A12	72	hr	1235	3306	4326	0.7641	0.7235
MCF7	Seliciclib	0.04	uM	LJP5	2	J06	72	hr	1235	4880	4356	1.1202	1.1289
MCF7	AZD7762	0.04	uM	LJP6	2	L06	72	hr	1235	1919	4070	0.4715	0.2918
MCF7	AZD7762	0.04	uM	LJP6	1	L06	72	hr	1235	1960	3974	0.4932	0.3150
MCF7	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1235	3316	3974	0.8344	0.7963
MCF7	AT-7519	0.04	uM	LJP6	2	K06	72	hr	1235	3573	4070	0.8778	0.8541
MCF7	AT-7519	0.04	uM	LJP6	3	K06	72	hr	1235	3793	4126	0.9192	0.9055
MCF7	AZD8055	0.04	uM	LJP6	1	A12	72	hr	1235	1330	3974	0.3347	0.0448
MCF7	Sorafenib	0.04	uM	LJP6	2	B12	72	hr	1235	3919	4070	0.9628	0.9564
MCF7	Seliciclib	0.04	uM	LJP5	3	J06	72	hr	1235	4855	4326	1.1222	1.1316
MCF7	GW843682X	0.04	uM	LJP6	1	B18	72	hr	1235	2869	3974	0.7219	0.6485
MCF7	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	1235	1089	4126	0.2639	-0.0699

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)